Showing results (251-260 of 465) with videos related to

Sort By:
Pageof 47
AIDS (London, England)|April 20, 2004
Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patientsLeonor Moreno, Carmen Quereda, Ana Moreno, et al.
AIDS (London, England)|April 12, 2005
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovirMaria Jesús Pérez-Elías, Santiago Moreno, Carolina Gutiérrez, et al.
HIV Medicine|December 28, 2020
Immune deficiency is a risk factor for severe COVID-19 in people living with HIVChristian Hoffmann, José L Casado, Georg Härter, et al.
Open Forum Infectious Diseases|August 27, 2025
Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case SeriesAna Moreno, Ruben Fernandez-Ibanez, Santos Del Campo, et al.
Ecohealth|September 23, 2015
Long-Term Surveillance of Aujeszky's Disease in the Alpine Wild Boar (Sus scrofa)Mario Chiari, Nicola Ferrari, Marco Bertoletti, et al.
Journal of the International AIDS Society|November 14, 2014
Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapyVicente Estrada, Susana Monge, Dulcenombre Gómez-Garre, et al.
One Health (Amsterdam, Netherlands)|January 19, 2026
Genomic epidemiology and phylogeographic reconstruction of West Nile virus 2 in Italy from 2011 to 2023Carla Della Ventura, Maya Carrera, Francesco Defilippo, et al.
Plos One|October 29, 2019
Dysregulated T helper type 1 (Th1) and Th17 responses in elderly hospitalised patients with infection and sepsisJohn D Coakley, Eamon P Breen, Ana Moreno-Olivera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2013
Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infectionsSergio Serrano-Villar, Carmen Quereda, Ana Moreno, et al.
Pageof 47